Polypid Ltd.

Biotechnology • Healthcare • Petah Tikva, Israel • PYPD (NCM)

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

972 7 4719 5700 18 Hasivim Street, Israel

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

PolyPid Ltd. (NASDAQ:PYPD) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

MarketBeat • Jan 3

PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors - GlobeNewswire

GlobeNewswire • Dec 16

PolyPid Calls February 2026 Extraordinary Meeting to Approve Board Chair Compensation - TipRanks

TipRanks • Dec 31

PolyPid stock rises after FDA supports NDA submission for D-PLEX100 - Investing.com

Investing.com • Dec 3

PolyPid Ltd. Appoints Brooke Story as Chairman of the Board of Directors - Quiver Quantitative

Quiver Quantitative • Dec 16

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has PolyPid Ltd. had layoffs?

No layoff events have been recorded for PolyPid Ltd. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does PolyPid Ltd. have?

PolyPid Ltd. has approximately 57 employees.

What industry is PolyPid Ltd. in?

PolyPid Ltd. operates in the Biotechnology industry, within the Healthcare sector.

Is PolyPid Ltd. a publicly traded company?

Yes, PolyPid Ltd. is publicly traded under the ticker symbol PYPD on the NCM. The company has a market capitalization of approximately $0.07 billion.

Where is PolyPid Ltd. headquartered?

PolyPid Ltd. is headquartered in Petah Tikva, Israel at 18 Hasivim Street, Israel.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.